Post-Transfusion Hepatitis

References

• Medical officers of the ministry of health. Homologous serum jaudice. Memorandum. Lancet 1943; i: 83–8
   Google Scholar
• Lürman. No initials were given in the original reference, only “Dr. Lurmen”. Eine Icterusepidemie. Berliner Klinische Wochenschrift 1885; 22: 20–3
   Google Scholar
• Aach R D., Szmuness W, Mosley J W., et al. Serum alanine aminotransferase of donors in relation to the risk of non-A, non-B hepatitis in recipients. The transfusion-transmitted viruses study. N Engl J Med 1981; 304: 989–94
   PubMed Web of Science ®Google Scholar
• Alter H J., Purcell R H., Holland P V., Ailing D W., Koziol D E. Donor transaminase and recipient hepatitis. Impact on blood transfusion services. JAMA 1981; 246: 630–4
   PubMed Web of Science ®Google Scholar
• Katchaki J N., Siem T H., Brouwer R, van Loon A M., van der Logt J TM. Post-transfusion non-A, non-B hepatitis in the Netherlands. Br Med J 1981; 282: 107–8
   PubMed Web of Science ®Google Scholar
• Cossart Y E., Kirsch S, Ismay S L. Post-transfusion hepatitis in Australia. Report of the Australian Red Cross Study. Lancet 1982; i: 208–13
   Google Scholar
• Tremolada F, Realdi G, Noventa F, et al. Post-transfusion hepatitis in Italy. Lancet 1982; i: 853–4
   Google Scholar
• Collins J D., Bassendine M F., Codd A A., Collins A, Ferner R E., James O FW. Prospective study of post-transfusion hepatitis after cardiac surgery in a British centre. Br Med J 1983; 287: 1422–4
   PubMedGoogle Scholar
• Hernández J M., Piqueras J, Carrera A, Triginer J. Post-transfusion hepatitis in Spain. A prospective study. Vox Sang 1983; 44: 231–7
   PubMed Web of Science ®Google Scholar
• Lehmann H, Schlaak M, Bernhard A. Die Posttrans-fusionhepatitis. Ergebnis einer 10jährigen prospektiven Studie zur Hepatitis nach Herzoperationen. Med Welt 1983; 34: 291–6
   PubMedGoogle Scholar
• Jullien A M., Courouce A M., Vedrenne J B., et al. Etude–prospective de I'incidence de I'hepatite post-transfusionnelle. Nouv Rev Fr Hematol 1985; 27: 133
   Google Scholar
• Ito S, Tsuji Y, Iwasaki A, Kitagawa N, Tamura Y, Fujii S. Relationship between guanase activity in donor blood and the incidence of posttransfusional non-A, non-B hepatitis, and a possible method for preventing posttransfusional hepatitis. Hepatology 1986; 6: 990–3
   PubMed Web of Science ®Google Scholar
• Koziol D E., Holland P V., Ailing D W., et al. Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood. Ann Intern Med 1986; 104: 488–95
   PubMed Web of Science ®Google Scholar
• Colombo M, Oldani S, Donato M F., et al. A multicenter, prospective study of posttransfusion hepatitis in Milan. Hepatology 1987; 7: 709–12
   PubMed Web of Science ®Google Scholar
• Widell A, Sundström G, Hansson B G., Fex G, Moestrup T, Nordenfelt E. Post-transfusion hepatitis type non-A, non-B in southern Sweden: occurrence and clinical significance. Scand J Infect Dis 1987; 19: 603–10
   PubMed Web of Science ®Google Scholar
• Feinman S V., Bern's B, Bojarski S. Posttransfusion hepatitis in Toronto, Canada. Gastroenterology 1988; 95: 464–9
   PubMed Web of Science ®Google Scholar
• Glück D, Gaus W, Wieland C, Kubanek B. Transfusions-hepatitis. Häufigkeit und Risikovergleich zwischen Blut-transfusion und Operation. Dtsch med Wochenschr 1988; 113: 1463–8
   PubMedGoogle Scholar
• Ito S, Tsuji Y, Kitagawa N, et al. Clinical value of the guanase screening test in donor blood for prevention of posttransfusional non-A, non-B hepatitis. Hepatology 1988; 8: 383–4
   PubMed Web of Science ®Google Scholar
• Mariniere A M., Smilovici A M., Ducos W, et al. NANB posttransfusion hepatitis. A French prospective study in open heart surgery patients. The XX Congress of the International Society of Blood Transfusion [Abstract]. Jas F & Carter Ltd, Manchester 1988; 56
   Google Scholar
• Mattsson L, Åberg B, Weiland O, Sellman M, Davilén J. Non-A, non-B hepatitis after open-heart surgery in Stockholm: Declining incidence after introduction of restrictions for blood donations due to the human immunodeficiency virus. Scand J Infect Dis 1988; 20: 371–6
   PubMed Web of Science ®Google Scholar
• Reesink H W., Leentvaar-Kuypers A, van der Poel C L., . Non-A, non-B posttransfusion hepatitis in open heart surgery patients in the Netherlands: preliminary results of a prospective study. Viral hepatitis and liver disease, A J. Zuckerman, et al. Alan R Liss, New York 1908; 8: 558–60
   Google Scholar
• Hoyos M, Sarrión J V., Pérez-Castellanos, et al. Prospective assessment of donor blood screening for antibody to hepatitis B core antigen as a means of preventing posttransfusion non-A, non-B, hepatitis. Hepatology 1989; 9: 449–51
   PubMed Web of Science ®Google Scholar
• Ohto H, Ninomiya K. Donor anti-HBc and ALT and non-A, non-B hepatitis. Transfusion 1989; 29: 277–8
   PubMed Web of Science ®Google Scholar
• Viola L, Pimentel E, Morgante P, Fernandez J L. Posttransfusion hepatitis in Buenos Aires, Argentina. Gastroenterology 1989; 97: 246
   PubMed Web of Science ®Google Scholar
• Esteban J I., González A, Hernández J M., et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 1990; 323: 1107–12
   PubMed Web of Science ®Google Scholar
• Wang J-T, Wang T-H, Lin J-T, Sheu J-C, Sung J-L, Chen D-S. Hepatitis C virus in a prospective study of posttransfusion non-A, non-B hepatitis in Taiwan. J Med Virol 1990; 32: 83–6
   PubMed Web of Science ®Google Scholar
• Ebeling F, Naukkarinen R, Hanhela R, et al. Post-transfusion hepatitis after open heart surgery in Finland–a prospective study. Transfusion Medicine 1991; 1: 103–8
   PubMedGoogle Scholar
• Choo Q-L, Kuo G, Weiner A J., Overby L R., Bradley D W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359–61
   PubMed Web of Science ®Google Scholar
• Blumberg B S., Alter H J., Visnich S. A “new” antigen in leukemia sera. JAMA 1965; 191: 541–6
   PubMed Web of Science ®Google Scholar
• Prince A M. Antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci USA 1968; 60: 814–21
   PubMed Web of Science ®Google Scholar
• Aach R D., Kahn R A. Post-transfusion Hepatitis: Current Perspectives. An Intern Med 1980; 92: 539–46
   PubMed Web of Science ®Google Scholar
• Memoranda. Viral hepatitis and tests for the Australia (hepatitis-associated) antigen and antibody. Bull WHO 1970; 42: 957–92
   PubMed Web of Science ®Google Scholar
• Hoofnagle J H. Posttransfusion hepatitis B. Transfusion 1990; 30: 384–6
   PubMed Web of Science ®Google Scholar
• Courouce A-M, Drouet J, LeMarrec N, Drouet A, Soulier J P. BLood donors positive for HBsAg and negative for anti-HBc antibody. Vox Sang 1985; 49: 26–33
   PubMedGoogle Scholar
• Feinstone S M., Kapikian A Z., Purcell R H. Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science 1973; 182: 1026–8
   PubMed Web of Science ®Google Scholar
• Feinstone S M., Kapikian A Z., Purcell R H., Alter H J., Holland P V. Transfusion-associated hepatitis not due to viral hepatitis type A or B. New Engl J Med 1975; 292: 767–70
   PubMed Web of Science ®Google Scholar
• Dienstag J L. Non-A, non-B hepatitis. I Recognition, epidemiology, and clinical features. Gastroenterology 1983; 85: 439–62
   PubMed Web of Science ®Google Scholar
• Scheuer P J. Non-A, non-B hepatitis (Editorial). Virchows Arch (A) 1989; 415: 301–3
   Google Scholar
• Dienstag J L. Non-A, non-B hepatitis. II. Experimental transmission, putative virus agents and markers, and prevention. Gastroenterology 1983; 85: 743–68
   PubMed Web of Science ®Google Scholar
• Kryger P, Aldershvile J, Christoffersen P, et al. the Copenhagen Hepatitis Acuta Programme (CHAP): Acute non-A, non-B hepatitis–clinical, epidemiological and histological characteristics. Scand J Infect Dis 1980; 12: 165–9
   PubMed Web of Science ®Google Scholar
• Norkrans G, Frösner G, Hermodsson S, Iwarson S. Clinical, epidemiological and prognostic aspects of hepatitis “non-A, non-B”–a comparison with hepatitis A and B. Scand J Infect Dis 1979; 11: 259–64
   PubMed Web of Science ®Google Scholar
• Weiland O. Hepatitis A. Aspects on prophylaxis and a comparison with hepatitis B and hepatitis non-A, non-B on epidemiology and prognosis. Scand J Infect Dis 1981; 1–73, Suppl 28
   PubMedGoogle Scholar
• Kato N, Hijikata M, Ootsuyama Y, et al. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 1990; 87: 9524–8
   PubMed Web of Science ®Google Scholar
• Kuo G, Choo Q-L, Alter H J., et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362–4
   PubMed Web of Science ®Google Scholar
• Ebeling F, Naukkarinen R, Leikola J. Posttransfusion hepatitis C in Finland. Transfusion Medicine 1991; 1: 109–13
   PubMedGoogle Scholar
• Esteban J I., Esteban R, Viladomiu L, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; ii: 294–6
   Google Scholar
• van der Poel C L., Reesink H W., Lelie P N., et al. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in the Netherlands. Lancet 1989; ii: 297–8
   Google Scholar
• van der Poel C L., Reesink H W., Schaasberg W, et al. Infectivity of blood seropositive for hepatitis C virus antibodies. Lancet 1990; 335: 558–60
   PubMed Web of Science ®Google Scholar
• Alter H J., Purcell R H., Shih J W., et al. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. N Engl J Med 1989; 321: 1494–500
   PubMed Web of Science ®Google Scholar
• Wang J-T, Wang T-H, Lin J-T, Sheu J-C, Sung J-L, Chen D-S. Hepatitis C virus in a prospective study of posttransfusion non-A, non-B hepatitis in Taiwan. J Med Virol 1990; 32: 83–6
   PubMed Web of Science ®Google Scholar
• Widell A, Sundström G, Hansson B G., Moestrup T, Nordenfelt E. Antibody to hepatitis-C-virus-related proteins in sera from alanine-aminotransferase-screened blood donors and prospectively studied recipients. Vox Sang 1991; 60: 28–33
   PubMed Web of Science ®Google Scholar
• Rollag H, Evesen S A., Fröland S S., Glomstein A. Prevalence of antibodies against hepatitis C virus in Norwegians with congenital coagulation factor defects treated with plasma products from small pools. Eur J Clin Microbiol Infect Dis 1990; 9: 612–4
   PubMed Web of Science ®Google Scholar
• Ebeling F, Rasi V, Naukkarinen R, Leikola J. Antibodies to hepatitis C virus and chronic liver disease among Finnish patients with haemophilia. Annals of Medicine 1990; 22: 393–6
   PubMed Web of Science ®Google Scholar
• Chen D-S, Kuo G C., Sung J-L, et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 1990; 162: 817–22
   PubMed Web of Science ®Google Scholar
• Alter M J., Hadler S C., Judson F N., et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990; 264: 2231–5
   PubMed Web of Science ®Google Scholar
• Melbye M, Biggar R J., Wanzin P, Krogsgaard K, Ebbesen P, Becker N. Sexual transmission of hepatitis C virus: cohort study (1981–9) among European homosexual men. Br Med J 1990; 301: 210–12
   PubMed Web of Science ®Google Scholar
• Idéo G, Bellati G, Pedraglio E, Bottelli R, Donzelli T, Putignano G. Intrafamilial transmission of hepatitis C virus. Lancet 1990; 335: 353
   PubMed Web of Science ®Google Scholar
• Hess G, Massing A, Rossol S, Schütt H, Clemens R, Meyer zum Büschenfelde K H. Hepatitis C virus and sexual transmission. Lancet 1989; ii: 987
   Google Scholar
• Wejstål R, Hermodsson S, Iwarson S, Norkrans G. Mother to infant transmission of hepatitis C virus infection. J Med Virol 1990; 30: 178–80
   PubMed Web of Science ®Google Scholar
• Anonymous. HCV and autoimmune liver disease (Editorial). Lancet 1990; 336: 1414–5
   PubMed Web of Science ®Google Scholar
• Bruix J, Barrera J M., Calvet X, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; ii: 1104–8
   Google Scholar
• Saito I, Miyamura T, Ohbayashi A, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 6547–9
   PubMed Web of Science ®Google Scholar
• Kiyosawa K, Tanaka E, Sodeyama T, et al. Transition of antibody to hepatitis C virus from chronic hepatitis to hepatocellular carcinoma. Jpn J Cancer Res 1990; 81: 1089–91
   PubMedGoogle Scholar
• Anonymous. The A to F of viral hepatitis (Editorial). Lancet 1990; 336: 1158–60
   PubMed Web of Science ®Google Scholar
• Stern H. Cytomegalovirus and EB virus infections of the liver. Br Med Bull 1972; 28: 180–5
   PubMed Web of Science ®Google Scholar
• Tegtmeier G E. Transfusion-transmittet cytomegalovirus infections: Significance and control. Vox Sang 1986; 51(Suppl 1)22–30
   PubMedGoogle Scholar
• Allen J G., Dawson D, Sayman W A., Humphreys E M., Benham R S., Havens I. Blood transfusion and serum hepatitis: use of monochloracetate as an antibacterial agent in plasma. Ann Surg 1959; 150: 455–68
   PubMed Web of Science ®Google Scholar
• Dodd R Y. Screening for hepatitis infectivity among blood donors. A model for blood safety? Arch Pathol Lab Med 1989; 113: 227–31
   PubMed Web of Science ®Google Scholar
• Widell A, Sundström G, Hansson B G., Fex G, Moestrup T, Nordenfelt E. Relation between donor transaminase and recipient hepatitis non-A, non-B in Sweden. Vox Sang 1988; 54: 154–9
   PubMed Web of Science ®Google Scholar
• Marugan R B., Zamora C, Moreno A, Erdozain Sosa J C., Hernandez F P., San Roman A L. Serum alanine amino-transferase (ALT) assay and incidence of posttransfusion non-A, non-B hepatitis. Transfusion 1989; 29: 751
   PubMed Web of Science ®Google Scholar
• Steinbrecher U P., Korvacs T OG, Gelly A, Touriguy M. Abnormal alanine aminotransferase level in blood units from donors in Montreal does not indicate high risk of transmitting hepatitis. Clin Invest Med 1983; 6: 327–30
   PubMed Web of Science ®Google Scholar
• Katchaki J N., Siem T H., Brouwer R. Post-transfusion hepatitis and serum alanine aminotransferase in blood donors. N Engl J Med 1981; 305: 403–4
   Google Scholar
• Stevens C E., Aach R D., Hollingen F B., et al. Hepatitis B virus antibody in blood donors and the occurrence of non-A, non-B hepatitis in transfusion recipients. An analysis of the transfusion-transmitted viruses study. Ann Intern Med 1984; 101: 733–8
   PubMed Web of Science ®Google Scholar
• Sugg U, Schenzle D, Hess G. Antibodies to hepatitis B core antigen in blood donors screened for alanine aminotransferase level and hepatitis non-A, non-B in recipients. Transfusion 1988; 28: 386–8
   PubMed Web of Science ®Google Scholar
• Aymard J P., Janot C, Gayet S, et al. Post-transfusion non-A, non-B hepatitis after cardiac surgery. Vox Sang 1986; 51: 236–8
   PubMed Web of Science ®Google Scholar
• Hanson M R., Polesky H F. Evaluation of routine anti-HBc screening of volunteer blood donors: á questionable surrogate test for non-A, non-B hepatitis. Transfusion 1987; 27: 107–8
   PubMed Web of Science ®Google Scholar
• Mimms L, Vallari D, Ducharme L, Holland P, Kuramoto I K., Zeldis J. Specificity of anti-HCV ELISA assessed by reactivity to three immunodominant HCV regions. Lancet 1990; 336: 1590–1
   PubMed Web of Science ®Google Scholar
• Ebeling F, Naukkarinen R, Leikola J. Recombinant immunoblot assay for hepatitis C virus antibody as predictor of infectivity. Lancet 1990; 335: 982–3
   PubMed Web of Science ®Google Scholar
• Weiner A J., Truett M A., Rosenblatt J, et al. HCV testing in low-risk population. Lancet 1990; 336: 695
   PubMed Web of Science ®Google Scholar
• Kolho E, Naukkarinen R, Krusius T. A study of Finnish blood donors using ELISA and RIBA [Abstract]. Second international symposium on HCV, November 8–9. Ortho Diagnostic Systems Inc. and Chiron Corporation, Los Angeles, California 1990; 108
   Google Scholar
• Alter H J. Discovery of the non-A, non-B hepatitis virus: The end of the beginning or the beginning of the end. Transfusion Medicine Reviews 1989; III: 77–81
   Google Scholar
• Triger D R., Preston F E. Annotation. Chronic liver disease in haemophiliacs. Br J Haematol 1990; 74: 241–5
   PubMed Web of Science ®Google Scholar